Device Trial Radar · NCT07921082
Effectiveness of Oxitard Gel Versus Physiotherapeutic and Pharmacological Interventions in Alleviating Oral Submucous Fibrosis: A Phase-II Randomized Control Trial
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Nov 15, 2026
Primary completion
Feb 15, 2027
Study completion Feb 28, 2027
Sponsor
- Lead sponsor
- Dow University of Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Effectiveness of Oxitard Gel Versus Physiotherapeutic and Pharmacological Interventions in Alleviating Oral Submucous Fibrosis: A Phase-II Randomized Control Trial Background Oral Submucous Fibrosis (OSMF) is a chronic, potentially malignant disorder of the oral mucosa. It causes progressively restricted mouth opening, reduced tongue protrusion with depapillation, submucosal fibrosis, blanching and loss of mucosal elasticity, and a shrunken uvula. It most often affects the buccal mucosa, palate and retromolar region, followed by the faucial pillars and pharynx. It is most common in South Asia. Areca nut chewing is the main cause, and commercial products such as gutka, pan masala and mawa add to the burden. Iron, vitamin B12 and folate deficiencies and capsaicin from chillies may also contribute. Irritants in areca nut and chillies trigger a juxta-epithelial inflammatory reaction. This shows first as burning, then vesicles, then ulceration. The epithelium becomes atrophic and poorly vascularised, so it heals poorly and scars. That scarring produces the fibrosis that restricts mouth opening, tongue movement and cheek flexibility. Treatment begins with stopping the habit. Early and intermediate cases are managed without surgery, usually with oral physiotherapy as an add-on. Operational Definition (Haider et al.) Clinical staging: Stage 1 is faucial bands only, Stage 2 is faucial and buccal bands, and Stage 3 is faucial, buccal and labial bands. Functional staging: Stage A is mouth opening of 20 mm or more, Stage B is 11-19 mm, and Stage C is 10 mm or less. Aim and Objectives The study compares conventional treatment (physiotherapy exercises plus multivitamins) with contemporary treatment (a novel herbal gel and Shekar's intraoral appliance) in OSMF patients. Its objectives are: Record sociodemographic and clinical features to categorise patients. Assess how well the herbal gel works. Assess how well Shekar's appliance works. Compare both contemporary treatments with conventional therapy. Hypotheses Null: there is no difference between conventional and contemporary treatments. Alternate: there is a significant difference between them. Methodology Design: pilot randomised controlled trial. Setting: Department of Oral Medicine, Dow International Dental College (DIDC), Karachi. Patients come from DIDC Hospital and Dr. Ishrat-ul-Ibad Khan Institute of Oral Health Sciences. Inclusion: OSMF patients with limited mouth opening, burning, fibrotic bands and blanched mucosa, in Haider Clinical Stages 1-2 and Functional Stages A-B. Exclusion: leukoplakic, erythroplakic or speckled lesions, non-healing ulcers or suspected malignancy; TMJ dysfunction; psychiatric disorders; other lesions that cause burning; and hypersensitivity to any ingredient of the gel or vitamins. Sample and allocation: 5 patients per group, 20 in total. The size was calculated in OpenEpi (95% confidence, 80% power). Patients are recruited by consecutive sampling and assigned to groups by a computer-generated random sequence. Herbal gel: made by Nutrimed Laboratories. It contains 1% each of Nigella sativa, tulsi, aloe vera, curcumin and lycopene, plus 0.1% vitamin E, in a carbomer 974P base. Data Collection and Blinding The study needs IRB approval from DUHS, and every participant gives written informed consent. Oral Medicine staff who are not on the research team do the examinations. A dental assistant keeps the group allocation sealed until the results are complete. Participants are not told which treatment they receive. The outcomes are: Mouth opening: measured between the incisors with a vernier caliper Burning sensation: Visual Analogue Scale (VAS) Cheek flexibility: measured at rest and with cheeks blown; the difference is recorded Tongue protrusion: in mm Mucosal colour: digital photographs Complete Blood Count: at the start and end of the study Intervention Groups Group 1: physiotherapy 3 times a day for 30 minutes, plus Pentovit H twice daily. Group 2: physiotherapy plus the herbal gel 3 times a day, with nothing to eat or drink for 30 minutes after each application. Group 3: Shekar's appliance 3 times a day for 15 minutes, plus Pentovit H. Group 4: Shekar's appliance 3 times a day for 15 minutes, plus the herbal gel 3 times a day. Patients log their compliance on record sheets that don't name their treatment. Follow-up, Duration and Analysis Patients are reviewed every 15 days for 3 months (6 visits), with a final CBC at the end. The study will take 9-12 months. Paired t-tests will measure change within each group, and unpaired t-tests will compare the groups, with p \< 0.05 counted as significant.
Conditions
- Oral and Maxillofacial Conditions
Interventions
Herbal FormulationDrug
Novel topical herbal gel (Nutrimed Laboratories, Pakistan) combining six antioxidant/anti-inflammatory agents in one formulation: Nigella sativa 1%, tulsi (Ocimum sanctum) 1%, aloe vera 1%, curcumin 1%, lycopene 1% and vitamin E 0.1%, in a carbomer 974P gel base with humectant, stabiliser, preservative, pH adjuster, flavour and water. Unlike single-agent curcumin or aloe vera gels, or oral herbal products such as Oxitard capsules or lycopene, it delivers all six agents together directly onto the affected oral mucosa. Patients apply a thin layer to the affected areas with a clean fingertip three times daily for 3 months, with no food or drink for 30 minutes afterwards. It is self-applied at home, non-invasive and contains no steroid or hyaluronidase. In this study it is used with conventional oral physiotherapy exercises (Group 2) or with Shekar's appliance (Group 4).
Shekar's applianceDevice
Shekar's appliance is a novel removable intraoral physiotherapy appliance for oral submucous fibrosis, first described by Reddy, Shinde and Khare (J Indian Acad Oral Med Radiol, 2021). It applies controlled, standardised stretching to the fibrotic oral tissues and muscles of mastication to gradually increase mouth opening. Unlike conventional stick exercises with wooden tongue depressors, which depend on the patient's own effort and technique, the appliance gives consistent, repeatable stretching. It needs no electrical equipment (unlike therapeutic ultrasound) and is non-invasive (unlike intralesional injections or surgery). Each patient is trained to insert, use and clean the appliance, and uses it at home three times daily for 15 minutes per session for 3 months. Technique is checked at each 15-day follow-up visit. In this study it replaces conventional exercises and is combined with Pentovit H (Group 3) or the novel herbal gel (Group 4).
Multivitamin/Mineral supplementsDietary supplement
Pentovit H, a commercially available oral multivitamin tablet, used as the conventional medical therapy for oral submucous fibrosis. Multivitamin supplementation is standard care because deficiencies of iron, vitamin B12 and folate are thought to contribute to disease progression. Participants take one tablet twice daily, in the morning and at night after meals, for 3 months. Unlike the novel herbal gel in this study, which is applied directly onto the oral mucosa, Pentovit H is taken by mouth and acts systemically. It contains no herbal extracts, steroids or antifibrotic agents. It is self-administered at home and is a low-cost product widely available in Pakistan. In this study it is the medication component of the conventional arm, combined with physiotherapy exercises (Group 1), and is also combined with Shekar's appliance (Group 3).
Conventional oral physiotherapy exercisesOther
Conventional home-based oral physiotherapy programme for oral submucous fibrosis, made up of seven exercises: stick (wooden tongue depressor) exercise, alphabet exercise, cheek-pushing exercise, balloon-blowing exercise, finger-snap exercise, isometric jaw exercise, and hot-pack massage of the cheeks. Together they stretch the fibrotic buccal tissues and muscles of mastication, improve cheek flexibility and help increase mouth opening. Participants are shown each exercise at the first visit and perform the full routine three times daily for 30 minutes per session for 3 months, with technique checked at each 15-day follow-up. Unlike Shekar's appliance, the exercises need no special device and rely on the patient's own effort, using simple items such as tongue depressors and balloons. In this study the exercises are the physiotherapy component of the conventional arm with Pentovit H (Group 1), and are also combined with the novel herbal gel (Group 2).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mouth openingTime frame: Measured at baseline and every 15 days for 3 months
- Burning sensationTime frame: Measured at baseline and every 15 days for 3 months
- Cheek flexibilityTime frame: Measured at baseline and every 15 days for 3 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dow University of Health Sciences
Karachi, Sindh, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.